No description available.

<p>  </p> <p>Breast cancer is a disease that impacts nearly one out of three women at some point in their life. Although the scientific community’s understanding of breast cancer development is actively researched, there is still a low 5-year survival rate of 30% following distant metastasis compared to the near 100% survival rate for localized disease. Epithelial to mesenchymal transition (EMT) is a known contributor to metastasis. Cells that undergo EMT shed cell-to-cell junctions and become fibroblastic like cells with differential extracellular matrix organization and increased mesenchymal gene expression. This change allows for greater cell motility and invasive potential, critical for metastasis. Our recent studies with single cell RNA sequencing demonstrate distinct populations of epithelial and mesenchymal cells. Several components of fibroblast growth factor receptor (FGFR) signaling are regulated during EMT. Fibroblast growth factor binding protein 1 (FGFBP1) is a known developmental factor that was observed at low expression in mesenchymal cells, with an unknown role in breast cancer. This study utilizes immunoblotting, mRNA analyses, immunofluorescence staining and novel 3D culture platform to investigate the regulation of FGFBP1 during EMT. FGFBP1 was consistently downregulated in HER2 transformed human mammary epithelial cells (HME2) during transforming growth factor β (TGF-Beta) induced EMT. Since FGFBP1 is acts as a secretory chaperone protein, secretion rate analysis was conducted at time periods throughout EMT showing rapid downregulation of secretion. Characterization of FGFBP1 regulation during EMT could lead to greater understanding of EMT and possibly a more sensitive marker for EMT relative to the current known markers.</p>

Endothelial cells separate the bloodstream from the underlying tissue and play a crucial role in vascular homeostasis. They also form an important barrier for vascular drug delivery. This thesis contains preliminary studies targeted at understanding the mechanisms of binding and transport across endothelial cells cultured in vitro. Specifically, the first study investigates how the recombinant source of Factor IX (FIX), a blood coagulant protein used in the treatment of Hemophilia B, impacts surface ligand binding (FIX to its specific receptors) to bovine aortic endothelial cells (BAECs). Competitive binding experiments between 125I-FIX and FIX were undertaken to quantify the interaction of recombinant and transgenic FIX with BAECs and human collagen IV and determine if there was a measurable difference in binding affinity. Results indicate limited specific binding of 125I-FIX to BAECs and no binding to human collagen IV. Concrete conclusions were not drawn from this data due to technical issues during the experimental process. The second study investigates insulin-like growth factor-I (IGF-I) transport across both BAEC and MAC-T cells, a mammary epithelial cell line, cultured on tissue culture inserts. IGF-I is a circulatory growth factor implicated in the regulation of cell division and tissue proliferation. Competitive binding experiments between 125I-IGF-I and unlabeled protein (IGF-I, Y60L-IGF-I, a mutant of IGF-I, and IGF Binding Protein-3 (IGFBP-3)) were undertaken to quantify the binding and transport of IGF-I under various experimental conditions. Results confirmed earlier work from the Williams' laboratory indicating that 125I-IGF-I transport was enhanced by incubation with its non-receptor-binding analog, Y60L-IGF-I, but cell surface associated 125I-IGF-I was decreased by its presence. Other studies were undertaken but conclusive results could not be drawn. / Master of Science

L’intensification des pratiques d’élevage s’est accompagnée de l’émergence de pathologies de production, notamment des mammites. Il s’agit d’une inflammation de la glande mammaire, d’origine bactérienne dans la majeure partie des cas. Les mammites constituent à elles seules la première source de pertes financières des cheptels bovins laitiers en France et dans le monde. Néanmoins aucun traitement prophylactique ne permet à ce jour une action préventive à long terme. Parmi les agents étiologiques majeurs des mammites, Escherichia coli (E. coli) tient son importance du fait de sa prévalence et de son impact sur les rendements et la qualité du lait. La part des facteurs de l’hôte dans la capacité à éliminer le pathogène causal est relativement avérée, tandis que le lien entre caractéristiques bactériennes et sévérité de l’infection est plus délicat à établir. Cette étude s’attache donc à déterminer si les interactions entre E. coli et la glande mammaire, en particulier les cellules épithéliales mammaires (CEM) et les neutrophiles, peuvent expliquer des degrés de sévérité variables. L’influence du lait sur ces interactions a également été investiguée. / Along with agricultural intensification of animal production, some pathologies have emerge, especially mastitis. This disease corresponds to an inflammation of the udder, and is generally provoked by bacterial infection. Mastitis on their own constitute the main source of financial impairments within dairy herds in France and worldwide. So far, there is no treatment able to prevent mastitis over time. Among major mastitis pathogens Escherichia coli (E. coli) is of great importance, because of its prevalence and its impacts on milk yield and quality. The mastitis severity has proven to be linked to host factors, but the implication of bacterial characteristics remains unknown. Thus, this study aimed at deciphering whether interactions between E. coli and the mammary gland, especially the mammary epithelial cells (MECs) and neutrophils, may explain a variability in mastitis severity. Influence of milk on these interactions was also investigated.

No description available.